Case Report
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastrointest Surg. Mar 27, 2013; 5(3): 68-72
Published online Mar 27, 2013. doi: 10.4240/wjgs.v5.i3.68
Table 1 Blood test findings on admission
Albumin, g/dL3.0 (3.9-4.9)
Total bilirubin, mg/dL0.3 (0.2-1.0)
Aspartate aminotransferase, IU/L7 (10-40)
Alanine aminotransferase, IU/L7 (5-45)
Blood urea nitrogen, mg/dL54 (7.2-20.0)
Creatinine, mg/dL8.2 (0.5-1.1)
Sodium, mmol/L131 (136-145)
Potassium, mmol/L4.1 (3.6-4.8)
Chlorine, mmol/L101 (99-109)
White blood cell, μL8000 (3100-9500)
Hemoglobin, g/dL9.9 (13.5-16.9)
Platelet /μL23.6 × 104 (15.1-34.9)
Fasting blood sugar, mg/dL290 (70-109)
Hemoglobin A1c7.6% (4.3%-5.8%)
Insulin, μIU/mL4860 (1.8-12.2)
C-peptide, ng/mL14.87 (0.61-2.09)
Binding rate of anti-insulin antibodies76.2% (< 0.4%)
Carcinoembryonic, ng/mL7.8 (< 5.0)
Pancreatic cancer-associated antigen-2, U/mL190 (< 150)
Table 2 Changes of three parameters around distal pancreatectomy
Before the operationAfter the operation (POD 14)
Serum insulin level (1.8-12.2 μIU/mL)4860553
Serum C-peptide level (0.61-2.09 ng/mL)14.875.28
Binding rate of anti-insulin antibodies (< 0.4%)76.270.3
Table 3 Reports of coexistent cases of pancreatic insulinoma and glucagonoma in Japan
CaseAge (yr)GenderChief compliantDefinitive diagnostic procedurePreoperative diagnosisOperative procedurePostoperative diagnosis
1[18]24MConsciousness disturbanceASVS + AGSix insulinoma at pancreatic tailDPFive insulinomas and two glucagonomas
2[19]73FConsciousness disturbanceASVSOne insulinoma at the region of GDA perfusionenucleationOne insulinoma and one glucagonoma
3[20]21MConsciousness disturbanceASVSOne insulinoma at the region of SpA perfusion1st enucleation, 2nd DPOne insulinoma and one glucagonoma
4[21]60FConsciousness disturbanceAGOne insulinoma at pancreatic tailDPOne insulinoma and one glucagonoma
5[22]59FConsciousness disturbanceCTOne insulinoma at pancreatic tailDPOne insulinoma and one glucagonoma
6 (our case)70MFasting hypoglycemiaCT + EUSOne insulinoma at pancreatic tailDPOne insulinoma and one glucagonoma